POAI 0.89 (-21.24%)
US74039M2008• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. POAI

Predictive Oncology (POAI) Competitor Comparison

We are evaluating the key criteria listed to compare Predictive Oncology (POAI) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

43 / 44

Gross Profits

38 / 40

Total Revenue

41 / 43

EBITDA

35 / 44

Free Cashflow

36 / 44

Quick Ratio

14 / 44

Earnings per Share

41 / 44

Dividend yield

0 / 13

Total Cash

35 / 44

Performance 3 years

44 / 44

Performance 5 years

44 / 44

Performance 10 years

44 / 44

Linearity 3 years

39 / 44

Linearity 5 years

43 / 44

Linearity 10 years

34 / 44

Total Rank

22 / 44

Dividend Rank

33 / 44

Valuation Rank

38 / 44

Piotroski Rank

32 / 44

Muliplier Rank

21 / 44

Valuation Rank - POAI ranking 38 / 44

These are the competitors of Predictive Oncology in the industry Medical Instruments & Supplies ranked by valuation rank
1. Hologic HOLX
0.86
2. electroCore ECOR
0.71
3. Dentsply Sirona XRAY
0.71
4. Merit Medical Systems MMSI
0.71
5. Bausch & Lomb BLCO
0.71
6. OraSure Technologies OSUR
0.71
7. Envista Holdings NVST
0.64
8. Baxter BAX
0.64
9. Becton, Dickinson BDX
0.64
10. Warby Parker WRBY
0.64
11. Masimo MASI
0.64
12. Alcon ALC
0.57
13. ResMed RMD
0.57
14. ICU Medical ICUI
0.57
15. West Pharmaceutical Services WST
0.57
16. Haemonetics HAE
0.57
17. AtriCure ATRC
0.5
18. iRhythm Technologies IRTC
0.5
19. AngioDynamics ANGO
0.5
20. Steris STE
0.5
21. Ekso Bionics Holdings EKSO
0.5
22. Pro-Dex PDEX
0.5
23. Cooper Companies COO
0.5
24. Femasys FEMY
0.5
25. Glaukos GKOS
0.5
26. NovoCure NVCR
0.5
27. Nephros NEPH
0.43
28. Ansell PD1.F
0.43
29. Atrion ATRI
0.43
30. Harvard Bioscience HBIO
0.43
31. Intuitive Surgical ISRG
0.43
32. KORU Medical Systems KRMD
0.43
33. LeMaitre Vascular LMAT
0.43
34. Akoya Biosciences AKYA
0.43
35. Teleflex TFX
0.43
36. Utah Medical Products UTMD
0.43
37. Pulse Biosciences PLSE
0.36
38. Predictive Oncology POAI
0.36
39. BioLife Solutions BLFS
0.36
40. Repligen RGEN
0.29
41. Staar Surgical STAA
0.29
42. NeuroMetrix NURO
0.29
43. NexGel NXGL
0.21
44. Microbot Medical MBOT
0.14
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.